Welcome Contact

TEL: +86-1528 0268 510

Email: sales@sex-pharm.com

ADD: 0805, No. 24, Dongming Rd, Xiamen, China.

Fnose--Specifically R&D for heart disease!

Consignment note

  Scott Alba, USA, order No.:SE806901 has been shipped.

  Peter Alexander, USA, order No.:SE806907 has been shipped.

  Darren Brown, GB, order No.:SE806911 has been shipped.

  Yehudi Ben, USA, order No.:SE806942 has been shipped.

  Xavier naidoo, ES, order No.:SE806939 has been shipped.

  Trevor Wright, IT, order No.:SE806969 has been shipped.

  Xavier Scott, USA, order No.:SE806949 has been shipped.

  Wythe Gino, FR, order No.:SE806937 has been shipped.

  Dick Gaby, DE, order No.:SE806958 has been shipped.

  Derrick, DE, order No.:SE807039 has been shipped.

  Xenos Timothy, USA, order No.:SE807136 has been shipped.

  Ximen Vern, USA, order No.:SE807145 has been shipped.

  Udeh Vernon, KR, order No.:SE807255 has been shipped.

  Ulrich Warren, KR, order No.:SE807265 has been shipped.

  Leif Stuart, MY, order No.:SE807368 has been shipped.

  Lynn Randall, MY, order No.:SE807439 has been shipped.

  Louis Patrick, USA, order No.:SE807440 has been shipped.

  Levi Matthew, USA, order No.:SE807521 has been shipped.

  Dana Lorin, USA, order No.:SE807611 has been shipped.

  York green, GB, order No.:SE807739 has been shipped.

Related Products

Long Term Use Of Oral Phosphodiesterase-5 Inhibitors May Treat And Prevent Recurrent Priapism

Based on previously published research linking dysregulated phosphodiesterase-5 (PDE-5) and ischemic priapism, Dr. Burnett and colleagues at Johns Hopkins University hypothesized that PDE-5 modulation may prevent or treat this condition.
They studied a total of 4 men (3 with Sickle Cell disease and 1 Idiopathic) with frequent episodes of priapism and administered either sildenafil citrate (25 or 50 mg) every morning or tadalafil (5 mg) three times weekly on a long-term basis.
Patients were followed and treated from 3-11 months with episodes of priapism significantly reduced to rare or occasional. The authors believe this encouraging response helps prove the dysregulated PDE-5 theory.
The authors concluded that the treatment with the PDE-5 inhibitors resets the dysregulation, thereby restoring normal function and protects against future recurrence.

Back Homepage